Portal Hypertension: Clinical and Experimental

The mission of the Portal Hypertension SIG is to promote collaboration and networking among investigators focused on understanding the pathophysiology, diagnosis, prevention and treatment of portal hypertension and its complications.

SIG Leadership

Chair
Elizabeth C. Verna, MD, MS, FAASLD
Vice Chair
Virginia Hernandez-Gea, MD, MD, PhD
Associate Lead
Tejasav Sehrawat, MD
Communication Lead
Coskun Ozer Demirtas, MD, FESBGH
Education Lead
Anahita Rabiee, MD
Trainee Lead
Alberto Zanetto, Jr, MD
At-Larges
Patrick Grant Northup, MD, FAASLD
Ashwani K. Singal, MD, MS, FACG, FAASLD
Staff Liaisons
Akuender Dot, MPH
Julie Hoffman, MBA